OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
19
Results
Show all
Save search
Copy query
Show results for
Unknown
(19)
Publication Date
Release Date
2024
(6)
2015
(3)
2025
(2)
2020
(2)
2026
(1)
2023
(1)
2022
(1)
2019
(1)
2016
(1)
2012
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
In vivo CRISPR screens reveal SCAF1 and USP15 as drivers of pancreatic cancer.
Not available
S-EPMC11189927
|
biostudies-literature
Cite
Atypical nested 22q11.2 duplications between LCR22B and LCR22D are associated with neurodevelopmental phenotypes including autism spectrum disorder with incomplete penetrance.
Not available
S-EPMC6393688
|
biostudies-literature
Cite
Retreatment, rechallenge, and escalation with subsequent immune checkpoint inhibitor therapies across cancers after initial failure.
Not available
S-EPMC12639429
|
biostudies-literature
Cite
Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosis.
Not available
S-EPMC10887367
|
biostudies-literature
Cite
Diagnostic utility of exome sequencing followed by research reanalysis in human brain malformations.
Not available
S-EPMC10914449
|
biostudies-literature
Cite
MECR Mutations Cause Childhood-Onset Dystonia and Optic Atrophy, a Mitochondrial Fatty Acid Synthesis Disorder.
Not available
S-EPMC5142118
|
biostudies-literature
Cite
A novel RFC1 repeat motif (ACAGG) in two Asia-Pacific CANVAS families.
Not available
S-EPMC7780484
|
biostudies-literature
Cite
Development of a centralised national AED (automated external defibrillator) network across all ambulance services in the United Kingdom.
Not available
S-EPMC11382004
|
biostudies-literature
Cite
ADORE: an open platform study of ruxolitinib in combination with other novel therapies in patients with myelofibrosis.
Not available
S-EPMC12362515
|
biostudies-literature
Cite
A pooled analysis of overall survival in COMFORT-I and COMFORT-II, 2 randomized phase III trials of ruxolitinib for the treatment of myelofibrosis.
Not available
S-EPMC4800694
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets